1 Introduction to Research & Analysis Reports
1.1 Enzyme Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Enzyme Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Enzyme Inhibitors Overall Market Size
2.1 Global Enzyme Inhibitors Market Size: 2022 VS 2029
2.2 Global Enzyme Inhibitors Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Enzyme Inhibitors Sales: 2018-2029
3 Company Landscape
3.1 Top Enzyme Inhibitors Players in Global Market
3.2 Top Global Enzyme Inhibitors Companies Ranked by Revenue
3.3 Global Enzyme Inhibitors Revenue by Companies
3.4 Global Enzyme Inhibitors Sales by Companies
3.5 Global Enzyme Inhibitors Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Enzyme Inhibitors Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Enzyme Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Enzyme Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Enzyme Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Enzyme Inhibitors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Enzyme Inhibitors Market Size Markets, 2022 & 2029
4.1.2 Proton Pump Inhibitors (PPIs)
4.1.3 Protease Inhibitors
4.1.4 Reverse Transcriptase Inhibitors
4.1.5 Aromatase Inhibitors
4.1.6 Kinase Inhibitors
4.1.7 Neuraminidase Inhibitors
4.1.8 Others
4.2 By Type – Global Enzyme Inhibitors Revenue & Forecasts
4.2.1 By Type – Global Enzyme Inhibitors Revenue, 2018-2023
4.2.2 By Type – Global Enzyme Inhibitors Revenue, 2024-2029
4.2.3 By Type – Global Enzyme Inhibitors Revenue Market Share, 2018-2029
4.3 By Type – Global Enzyme Inhibitors Sales & Forecasts
4.3.1 By Type – Global Enzyme Inhibitors Sales, 2018-2023
4.3.2 By Type – Global Enzyme Inhibitors Sales, 2024-2029
4.3.3 By Type – Global Enzyme Inhibitors Sales Market Share, 2018-2029
4.4 By Type – Global Enzyme Inhibitors Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Enzyme Inhibitors Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Research Institution
5.1.4 Others
5.2 By Application – Global Enzyme Inhibitors Revenue & Forecasts
5.2.1 By Application – Global Enzyme Inhibitors Revenue, 2018-2023
5.2.2 By Application – Global Enzyme Inhibitors Revenue, 2024-2029
5.2.3 By Application – Global Enzyme Inhibitors Revenue Market Share, 2018-2029
5.3 By Application – Global Enzyme Inhibitors Sales & Forecasts
5.3.1 By Application – Global Enzyme Inhibitors Sales, 2018-2023
5.3.2 By Application – Global Enzyme Inhibitors Sales, 2024-2029
5.3.3 By Application – Global Enzyme Inhibitors Sales Market Share, 2018-2029
5.4 By Application – Global Enzyme Inhibitors Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Enzyme Inhibitors Market Size, 2022 & 2029
6.2 By Region – Global Enzyme Inhibitors Revenue & Forecasts
6.2.1 By Region – Global Enzyme Inhibitors Revenue, 2018-2023
6.2.2 By Region – Global Enzyme Inhibitors Revenue, 2024-2029
6.2.3 By Region – Global Enzyme Inhibitors Revenue Market Share, 2018-2029
6.3 By Region – Global Enzyme Inhibitors Sales & Forecasts
6.3.1 By Region – Global Enzyme Inhibitors Sales, 2018-2023
6.3.2 By Region – Global Enzyme Inhibitors Sales, 2024-2029
6.3.3 By Region – Global Enzyme Inhibitors Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Enzyme Inhibitors Revenue, 2018-2029
6.4.2 By Country – North America Enzyme Inhibitors Sales, 2018-2029
6.4.3 US Enzyme Inhibitors Market Size, 2018-2029
6.4.4 Canada Enzyme Inhibitors Market Size, 2018-2029
6.4.5 Mexico Enzyme Inhibitors Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Enzyme Inhibitors Revenue, 2018-2029
6.5.2 By Country – Europe Enzyme Inhibitors Sales, 2018-2029
6.5.3 Germany Enzyme Inhibitors Market Size, 2018-2029
6.5.4 France Enzyme Inhibitors Market Size, 2018-2029
6.5.5 U.K. Enzyme Inhibitors Market Size, 2018-2029
6.5.6 Italy Enzyme Inhibitors Market Size, 2018-2029
6.5.7 Russia Enzyme Inhibitors Market Size, 2018-2029
6.5.8 Nordic Countries Enzyme Inhibitors Market Size, 2018-2029
6.5.9 Benelux Enzyme Inhibitors Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Enzyme Inhibitors Revenue, 2018-2029
6.6.2 By Region – Asia Enzyme Inhibitors Sales, 2018-2029
6.6.3 China Enzyme Inhibitors Market Size, 2018-2029
6.6.4 Japan Enzyme Inhibitors Market Size, 2018-2029
6.6.5 South Korea Enzyme Inhibitors Market Size, 2018-2029
6.6.6 Southeast Asia Enzyme Inhibitors Market Size, 2018-2029
6.6.7 India Enzyme Inhibitors Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Enzyme Inhibitors Revenue, 2018-2029
6.7.2 By Country – South America Enzyme Inhibitors Sales, 2018-2029
6.7.3 Brazil Enzyme Inhibitors Market Size, 2018-2029
6.7.4 Argentina Enzyme Inhibitors Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Enzyme Inhibitors Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Enzyme Inhibitors Sales, 2018-2029
6.8.3 Turkey Enzyme Inhibitors Market Size, 2018-2029
6.8.4 Israel Enzyme Inhibitors Market Size, 2018-2029
6.8.5 Saudi Arabia Enzyme Inhibitors Market Size, 2018-2029
6.8.6 UAE Enzyme Inhibitors Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Enzyme Inhibitors Major Product Offerings
7.1.4 AstraZeneca Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Enzyme Inhibitors Major Product Offerings
7.2.4 GlaxoSmithKline Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Enzyme Inhibitors Major Product Offerings
7.3.4 Bayer Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Enzyme Inhibitors Major Product Offerings
7.4.4 Novartis Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Enzyme Inhibitors Major Product Offerings
7.5.4 Roche Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Ranbaxy Laboratories
7.6.1 Ranbaxy Laboratories Company Summary
7.6.2 Ranbaxy Laboratories Business Overview
7.6.3 Ranbaxy Laboratories Enzyme Inhibitors Major Product Offerings
7.6.4 Ranbaxy Laboratories Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.6.5 Ranbaxy Laboratories Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Enzyme Inhibitors Major Product Offerings
7.7.4 Johnson & Johnson Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Summary
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Enzyme Inhibitors Major Product Offerings
7.8.4 Abbott Laboratories Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.8.5 Abbott Laboratories Key News & Latest Developments
7.9 Takeda
7.9.1 Takeda Company Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Enzyme Inhibitors Major Product Offerings
7.9.4 Takeda Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.9.5 Takeda Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Enzyme Inhibitors Major Product Offerings
7.10.4 Pfizer Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Sanofi
7.11.1 Sanofi Company Summary
7.11.2 Sanofi Enzyme Inhibitors Business Overview
7.11.3 Sanofi Enzyme Inhibitors Major Product Offerings
7.11.4 Sanofi Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.11.5 Sanofi Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Enzyme Inhibitors Business Overview
7.12.3 Merck Enzyme Inhibitors Major Product Offerings
7.12.4 Merck Enzyme Inhibitors Sales and Revenue in Global (2018-2023)
7.12.5 Merck Key News & Latest Developments
8 Global Enzyme Inhibitors Production Capacity, Analysis
8.1 Global Enzyme Inhibitors Production Capacity, 2018-2029
8.2 Enzyme Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Enzyme Inhibitors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Enzyme Inhibitors Supply Chain Analysis
10.1 Enzyme Inhibitors Industry Value Chain
10.2 Enzyme Inhibitors Upstream Market
10.3 Enzyme Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Enzyme Inhibitors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の酵素阻害剤市場予測2023-2029：プロトンポンプ阻害剤（PPI）、プロテアーゼ阻害剤、逆転写酵素阻害剤、アロマターゼ阻害剤、キナーゼ阻害剤、ノイラミニダーゼ阻害剤、その他 |
| 【英語タイトル】Enzyme Inhibitors Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5541 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：71 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の酵素阻害剤市場規模と予測を収録しています。・世界の酵素阻害剤市場：売上、2018年-2023年、2024年-2029年 ・世界の酵素阻害剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の酵素阻害剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「プロトンポンプ阻害剤（PPI）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 酵素阻害剤のグローバル主要企業は、AstraZeneca、 GlaxoSmithKline、 Bayer、 Novartis、 Roche、 Ranbaxy Laboratories、 Johnson & Johnson、 Abbott Laboratories、 Takeda、 Pfizer、 Sanofi、 Merckなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、酵素阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の酵素阻害剤市場：タイプ別、2018年-2023年、2024年-2029年 世界の酵素阻害剤市場：タイプ別市場シェア、2022年 ・プロトンポンプ阻害剤（PPI）、プロテアーゼ阻害剤、逆転写酵素阻害剤、アロマターゼ阻害剤、キナーゼ阻害剤、ノイラミニダーゼ阻害剤、その他 世界の酵素阻害剤市場：用途別、2018年-2023年、2024年-2029年 世界の酵素阻害剤市場：用途別市場シェア、2022年 ・病院、研究機関、その他 世界の酵素阻害剤市場：地域・国別、2018年-2023年、2024年-2029年 世界の酵素阻害剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における酵素阻害剤のグローバル売上、2018年-2023年 ・主要企業における酵素阻害剤のグローバル売上シェア、2022年 ・主要企業における酵素阻害剤のグローバル販売量、2018年-2023年 ・主要企業における酵素阻害剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 AstraZeneca、 GlaxoSmithKline、 Bayer、 Novartis、 Roche、 Ranbaxy Laboratories、 Johnson & Johnson、 Abbott Laboratories、 Takeda、 Pfizer、 Sanofi、 Merck ************************************************************* ・調査・分析レポートの概要 酵素阻害剤市場の定義 市場セグメント 世界の酵素阻害剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の酵素阻害剤市場規模 世界の酵素阻害剤市場規模：2022年 VS 2029年 世界の酵素阻害剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの酵素阻害剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の酵素阻害剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：プロトンポンプ阻害剤（PPI）、プロテアーゼ阻害剤、逆転写酵素阻害剤、アロマターゼ阻害剤、キナーゼ阻害剤、ノイラミニダーゼ阻害剤、その他 酵素阻害剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、研究機関、その他 酵素阻害剤の用途別グローバル売上・予測 ・地域別市場分析 地域別酵素阻害剤市場規模 2022年と2029年 地域別酵素阻害剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） AstraZeneca、 GlaxoSmithKline、 Bayer、 Novartis、 Roche、 Ranbaxy Laboratories、 Johnson & Johnson、 Abbott Laboratories、 Takeda、 Pfizer、 Sanofi、 Merck ... |
Enzyme inhibitors are naturally occurring molecules that attach to the enzymes to inhibit the culture of harmful pathogens and enhance metabolism. They have varied applications as drugs in therapeutics and pesticides for agricultural activities.
This report aims to provide a comprehensive presentation of the global market for Enzyme Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme Inhibitors. This report contains market size and forecasts of Enzyme Inhibitors in global, including the following market information:
Global Enzyme Inhibitors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Enzyme Inhibitors Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Enzyme Inhibitors companies in 2022 (%)
The global Enzyme Inhibitors market was valued at US$ 147910 million in 2022 and is projected to reach US$ 155960 million by 2029, at a CAGR of 0.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In recent years, the market has witnessed significant growth owing to outsourcing manufacturing process coupled with effective & accurate therapies for chronic diseases such as cancer, respiratory diseases, and others.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Enzyme Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enzyme Inhibitors Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Enzyme Inhibitors Market Segment Percentages, by Type, 2022 (%)
Proton Pump Inhibitors (PPIs)
Protease Inhibitors
Reverse Transcriptase Inhibitors
Aromatase Inhibitors
Kinase Inhibitors
Neuraminidase Inhibitors
Others
Global Enzyme Inhibitors Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Enzyme Inhibitors Market Segment Percentages, by Application, 2022 (%)
Hospital
Research Institution
Others
Global Enzyme Inhibitors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Enzyme Inhibitors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enzyme Inhibitors revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Enzyme Inhibitors revenues share in global market, 2022 (%)
Key companies Enzyme Inhibitors sales in global market, 2018-2023 (Estimated), (Units)
Key companies Enzyme Inhibitors sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
GlaxoSmithKline
Bayer
Novartis
Roche
Ranbaxy Laboratories
Johnson & Johnson
Abbott Laboratories
Takeda
Pfizer
Sanofi
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Enzyme Inhibitors, market overview.
Chapter 2: Global Enzyme Inhibitors market size in revenue and volume.
Chapter 3: Detailed analysis of Enzyme Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enzyme Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Enzyme Inhibitors capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の酵素阻害剤市場予測2023-2029：プロトンポンプ阻害剤（PPI）、プロテアーゼ阻害剤、逆転写酵素阻害剤、アロマターゼ阻害剤、キナーゼ阻害剤、ノイラミニダーゼ阻害剤、その他] (コード：MMG23JU5541)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の酵素阻害剤市場予測2023-2029：プロトンポンプ阻害剤（PPI）、プロテアーゼ阻害剤、逆転写酵素阻害剤、アロマターゼ阻害剤、キナーゼ阻害剤、ノイラミニダーゼ阻害剤、その他]についてメールでお問い合わせ |
